NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
30.80
+0.40 (1.32%)
Dec 20, 2024, 4:00 PM EST - Market closed
NovoCure Market Cap
NovoCure has a market cap or net worth of $3.33 billion as of December 20, 2024. Its market cap has increased by 142.12% in one year.
Market Cap
3.33B
Enterprise Value
3.05B
1-Year Change
142.12%
Ranking
Category
Stock Price
$30.80
Market Cap Chart
Since October 2, 2015, NovoCure's market cap has increased from $1.51B to $3.33B, an increase of 120.51%. That is a compound annual growth rate of 8.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 3.33B | 108.89% |
| Dec 29, 2023 | 1.60B | -79.28% |
| Dec 30, 2022 | 7.70B | -1.24% |
| Dec 31, 2021 | 7.79B | -55.75% |
| Dec 31, 2020 | 17.62B | 111.21% |
| Dec 31, 2019 | 8.34B | 167.82% |
| Dec 31, 2018 | 3.11B | 72.52% |
| Dec 29, 2017 | 1.81B | 164.99% |
| Dec 30, 2016 | 681.20M | -63.57% |
| Dec 31, 2015 | 1.87B | 23.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perrigo Company | 3.51B |
| Oscar Health | 3.48B |
| CRISPR Therapeutics AG | 3.48B |
| Rhythm Pharmaceuticals | 3.45B |
| Verona Pharma | 3.44B |
| MoonLake Immunotherapeutics | 3.29B |
| Inari Medical | 3.25B |
| Envista Holdings | 3.22B |